Direct Meds logo

Direct Meds Review

6.4
★★★☆☆3.2/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.4/10

Best for: listed for disclosure only; see its FDA warning and BBB complaints first

Direct Meds scores below our bar on medical oversight. Read the score breakdown before signing up.

Semaglutide

$297/mo · starting price

Tirzepatide

$399/mo · starting price

Price checked on Direct Meds' site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

PartnerDirect Meds is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money

Direct Meds is a telehealth provider offering compounded semaglutide and tirzepatide in injection and sublingual formats. Listed here with full disclosure of a September 2025 FDA warning letter for misleading marketing, plus a documented pattern of customers reporting unexpected 3-month commitment charges. See warnings and cons before considering.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedOral OptionSemaglutideTirzepatideLegitScript Verified

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Direct Meds logo
3.2 / 5
Our editorial rating
Visit Direct Meds →

from $297/mo · no insurance needed

Direct Meds at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$297/mo (starting price)
What's included
Medication · Consult · Shipping
FDA status
1 FDA warning letter on record; see below

How we scored Direct Meds

Each dimension is scored algorithmically from Direct Meds'published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

5.4/10

Direct Meds' headline is $297/mo. Compare it with other programs on the same plan basis.

Effectiveness25%

8.1/10

Direct Meds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.0/10

Online intake and platform experience (consult included in the price); 5 platform features disclosed.

Trust & Safety15%

5.2/10

Core details confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).

Accessibility10%

6.0/10

Direct Meds' exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

5.8/10

Direct Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Direct Meds review

Last checked November 2026
  • Confirmed current pricing across 4 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$249–$399/mo across 4 dose/plan tiers (checked November 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
An active letter is on file for this provider; see below

What to expect when you sign up with Direct Meds

We walked Direct Meds' public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Complete a free secure online assessment/intake quiz (stated under 5 minutes, no appointments needed).
  2. 2A licensed U.S. provider reviews your assessment and builds a treatment plan.
  3. 3Once qualified, your prescription is reviewed and approved within hours.
  4. 4Approved medication ships within 1-2 business days from a U.S.-certified pharmacy with free tracked delivery.
Price shown before you start
  • The how-it-works page lists pricing before intake (plans start at $249/mo sublingual semaglutide, $297/mo injections); the homepage emphasizes 'no monthly memberships' and 'no hidden fees.'
  • Entirely online with 'no appointments needed.'
  • The homepage shows 'No Hidden Costs. Ever.' and 'No Membership Fees'; the Terms allow a return when the medication is denied by a Direct Meds doctor.
  • Ships within 1-2 business days with free priority/tracked shipping.
  • Support via patient-portal messaging, email, and phone during unspecified business hours.

Direct Meds customer support

GLP-1 medications Direct Meds offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Peptides Direct Meds offers

Beyond GLP-1s, Direct Meds also offers these peptides. Tap any for our evidence-based guide.

Pricing

Prices re-verified

SublingualCompounded
$249/mo
semaglutide

Portal shows 'As low as $249.00'; some dosages price as low as $237, on a 90-day supply.

InjectionCompounded
$297/mo
semaglutide

'As low as $297.00 or $9.58 per day', on a 90-day supply shipped at once and billed monthly. 30-, 90-, 180- and 360-day supplies are listed.

SublingualCompounded
$299/mo
tirzepatide

'As low as $299.00, or $9.65 per day', on a 90-day supply billed monthly.

InjectionCompounded
$399/mo
tirzepatide

'As low as $399.00 or $12.87 per day', on a 90-day supply billed monthly.

Ready to get started?

Plans and promotions change often, so check Direct Meds' current pricing and active discounts before you decide.

See Direct Meds pricing →

What we like

  • Semaglutide and tirzepatide available in both injection and sublingual formats
  • All-inclusive pricing covers medication, nurse support, digital follow-ups, and free tracked shipping
  • LegitScript Certified
  • Accepts HSA and FSA payments for all GLP-1 treatments

Watch-outs

  • FDA warning letter (Sept 2025) for marketing compounded GLP-1s as equivalent to FDA-approved drugs
  • BBB rating 1.12/5 across 226 reviews citing a hidden 3-month commitment (charges of $940+ when buyers expected 1 month)
  • Wide rating gap (Trustpilot 4.6/5 vs BBB 1.12/5) points to review-solicitation bias or unresolved complaints
  • Not available in Mississippi, Louisiana, or California
  • Compounded only: no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Auto-renews unless you turn off auto-refill 48 hours before the next charge; complaints report long hold times and retention friction

The verdict: a provider we list as a warning, not a recommendation

Direct Meds is a telehealth company selling compounded semaglutide and tirzepatide. We include it here for one reason: so you can see, in plain view, the two things that should give any shopper pause. First, the FDA sent Direct Meds a warning letter in September 2025. Second, its Better Business Bureau profile is full of customers who say they were charged for a three-month supply when they thought they were buying one month. Neither of those is a small footnote. If you read nothing else, read the trust section below before you hand over a card number.

The headline price is $297 a month for sublingual semaglutide, which sits above the category median of $179. On paper the bundle is generous. In practice, the way that bundle gets billed is exactly where the complaints come from.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.

How the pricing works, and where it bites

Direct Meds advertises all-inclusive pricing: the medication, nurse support, digital follow-ups, and free tracked shipping are all folded into one number. That part is real and, taken alone, is reasonable. The problem is the structure underneath the number.

  • Sublingual semaglutide runs $297 a month, the figure quoted in its marketing.
  • Injectable semaglutide is priced a step higher than the sublingual drops.
  • Tirzepatide injections sit at the top of its menu; sublingual tirzepatide costs about the same as semaglutide shots.
  • Plans auto-renew: you have to turn off auto-refill in the account portal at least 48 hours before the next charge, and the prices are for a 90-day supply shipped at once and billed monthly. At GobyMeds there is no refill setting to remember: you place each order yourself, and nothing is charged until you do.

The recurring theme in BBB reviews is that the advertised monthly figure is not what people were actually charged. Customers describe being billed for a three-month commitment, and one verbatim complaint cites a charge of over nine hundred dollars for a three-month supply the buyer says they never agreed to. Whether you read that as a deliberate trap or a badly disclosed default, the result is the same: the price you see is not reliably the price you pay. Confirm the exact billing terms in writing before you order, and assume the commitment is longer than one month unless told otherwise. Lttl avoids that trap by putting the commitment length next to every price on its public plans page.

The medications: compounded only, in drops or shots

Direct Meds offers both leading GLP-1 molecules, semaglutide and tirzepatide, and, unusually, in both an injectable and a sublingual (under-the-tongue) format. The oral option is the main point of difference for needle-averse patients, since most compounding-focused telehealth sells injections only. MadeMed is another choice here, with a compounded tirzepatide tablet that dissolves under the tongue.

Everything here is compounded. There is no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro on the menu. Compounded GLP-1s are made by outsourcing pharmacies rather than the brand manufacturer, and they are not FDA-reviewed for safety or effectiveness the way the brand drugs are. The company says it holds a LegitScript certification and that licensed third-party compounding pharmacies fill its prescriptions, but it no longer names them. But certification of the storefront is not the same as the FDA standing behind the product in the vial.

The FDA warning letter you should know about

In September 2025 the FDA issued warning letters to 55 online telehealth companies selling compounded GLP-1 drugs, and Direct Meds was one of them. The specific issue cited in its letter was marketing language, including claims like 'same active ingredient as Ozempic and Wegovy' and 'clinically proven ingredients'. The FDA held those to be false or misleading because they imply the compounded product is equivalent to an FDA-approved drug. It isn't.

Beyond the legal technicality, the letter tells you the company was, in the regulator's view, overselling what it ships. When you read the rest of its marketing, read it with that in mind.

The review-score gap nobody should ignore

Direct Meds carries a Trustpilot rating of 4.6 out of 5 across thousands of reviews, and a BBB rating of 1.12 out of 5 across 226 reviews. A gap that wide usually signals heavy review solicitation on one platform and a backlog of unresolved disputes on the other. The BBB complaints cluster tightly around the same story: surprise multi-month charges, auto-renewal that's hard to stop, long hold times, and friction when you try to cancel. When two scoreboards disagree this loudly, the one full of detailed, specific complaints is the one to weight.

Who might consider it, and who should walk

There is a narrow case for Direct Meds: someone who specifically wants a sublingual GLP-1, who reads and accepts a multi-month commitment up front, and who is comfortable with compounded medication despite the FDA's marketing objections. If the oral format is what draws you, Tru2u also sells compounded semaglutide and tirzepatide as tablets, and none of the FDA warning letters we track names it. One caveat: it doesn't name its pharmacy. For most people, the safer move is a provider without a warning letter and without a documented billing-complaint pattern. If you have insurance or can reach the brand drugs, skip compounded entirely. If you value being able to cancel cleanly, the cancellation friction here is a repeated complaint.

Bottom line

Direct Meds bundles a complete GLP-1 program, including a rare oral format, into one all-inclusive monthly price, and it says it holds a LegitScript certification. But a September 2025 FDA warning for misleading marketing, a 1.12-out-of-5 BBB rating built on surprise three-month charges, and an auto-renewal model that's hard to exit add up to a profile we list for disclosure rather than recommend. We score its trust low for exactly these reasons; see our scoring methodology for how that's weighed. If you proceed, get the billing terms in writing first, and treat every marketing claim with skepticism.

The Bottom Line

Direct Meds scores below our bar on medical oversight. Read the score breakdown before signing up.

Score: 6.4/10Best for: listed for disclosure only; see its FDA warning and BBB complaints firstFrom: $297/mo

Ready to start with Direct Meds?

From $297/mo. See current pricing and start your online intake.

Direct Meds might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.

Alternatives to Direct Meds

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →

Head-to-head

Compare Direct Meds vs…

Direct Meds scores6.4/10

Side-by-side pricing, medications and scores. Pick a matchup.

All 45 Direct Meds comparisons

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Readers should weigh serious concerns before considering Direct Meds. In September 2025, Direct Meds received an FDA warning letter as part of an enforcement action against 55 telehealth companies selling compounded GLP-1 drugs with misleading marketing, including claims such as "Same active ingredient as Ozempic and Wegovy" that regulators found to be false or misleading. On the Better Business Bureau, Direct Meds holds a 1.12/5 rating across 226 reviews documenting a consistent pattern of customers being charged for three-month supplies ($940+) they did not intend to order. Direct Meds says it is LegitScript-certified and that prescriptions are filled by licensed third-party compounding pharmacies, though it no longer names them. Our editorial position: listed for transparency and reader awareness, not recommended.
Direct Meds is not itself a pharmacy. It is a telehealth platform whose Terms say “Prescriptions are fulfilled by licensed third-party compounding pharmacies.” The site does not name those pharmacies. Direct Meds LLC holds LegitScript certification, which certifies legal operation within U.S. healthcare regulations. However, the company received an FDA warning letter in September 2025 for marketing compounded GLP-1 drugs with claims the FDA determined were false or misleading, specifically representations suggesting compounded products were equivalent to FDA-approved drugs. A warning letter is a serious compliance event regardless of LegitScript status. The BBB also records 226 customer reviews at a 1.12/5 rating, with complaints focused on undisclosed three-month commitment charges. We recommend thoroughly researching these issues before ordering.
Direct Meds dispenses compounded semaglutide, not FDA-approved brand-name semaglutide drugs such as Ozempic or Wegovy. Compounded semaglutide contains the same active ingredient but is prepared by a compounding pharmacy rather than manufactured by Novo Nordisk, and it has not undergone FDA's approval process for safety, efficacy, and quality as a finished drug. The FDA's September 2025 warning letter to Direct Meds specifically cited the company for making claims suggesting its compounded product was equivalent to FDA-approved semaglutide, a characterization the FDA found to be false and misleading. Compounded semaglutide is not an FDA-approved finished drug product regardless of where it is dispensed.
Direct Meds lists $249/month for sublingual semaglutide and $297/month for injectable semaglutide. Compounded tirzepatide is $299/month sublingual and $399/month by injection. Each of these prices is for a 90-day supply shipped at once and billed monthly. Direct Meds advertises all-inclusive pricing covering medication, nurse support, shipping, and digital follow-ups. However, the BBB's documented complaint pattern indicates that some customers have been enrolled in an undisclosed three-month commitment and charged approximately $940 or more upfront without realizing they had agreed to a multi-month billing cycle. We strongly recommend reading the full billing terms, including any commitment period, before entering payment information.
Direct Meds doesn't use public promo or coupon codes. Third-party sites advertising "Direct Meds discount codes" are typically fake; any current offer applies automatically through the link on this page.
The main red flag is an FDA warning letter on file, which this review flags. Read it before starting. We also note: FDA warning letter (Sept 2025) for marketing compounded GLP-1s as equivalent to FDA-approved drugs; BBB rating 1.12/5 across 226 reviews citing a hidden 3-month commitment (charges of $940+ when buyers expected 1 month); wide rating gap (Trustpilot 4.6/5 vs BBB 1.12/5) points to review-solicitation bias or unresolved complaints.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

Direct Meds received an FDA warning letter dated September 9, 2025

The letter concerns unlawful sale of unapproved and misbranded drugs to United States consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Direct Meds review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Direct Meds' current pricing

Plans from $297/mo. Start the online intake to check eligibility and today's price.